Cargando…

Diagnostic Value of Cytokeratin 34 beta E12 (Ck34βE12) and α-Methylacyl-CoA racemase (AMACR) Immunohistochemical Expression in Prostatic Lesions

BACKGROUND & OBJECTIVE: Some prostatic lesions contain small suspicious foci for prostatic carcinoma in which the morphological features are equivocal. Two immunohistochemical markers namely, cytokeratin 34 beta E12 (Ck34βE12) and α-Methylacyl-CoA racemase (AMACR), were evaluated in these lesion...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hasan, Ikram A., Gaidan, Hiba Ahmed, Al-kaabi, Methaq Mueen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iranian Society of Pathology 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354068/ https://www.ncbi.nlm.nih.gov/pubmed/32754219 http://dx.doi.org/10.30699/ijp.2020.113544.2229

Ejemplares similares

Alpha-Methylacyl-CoA Racemase (AMACR), a Potential New Biomarker for Glioblastoma
por: Lee, Hyunji, et al.
Publicado: (2020)

α-methylacyl-CoA racemase (AMACR) expression in chordomas differentiates them from chondrosarcomas
por: Aviel-Ronen, Sarit, et al.
Publicado: (2016)

α-Methylacyl-CoA racemase (AMACR) serves as a prognostic biomarker for the early recurrence/metastasis of HCC
por: Xu, Bo, et al.
Publicado: (2014)

Exploiting the transcriptional specificity of the alpha-methylacyl-CoA racemase AMACR promoter for the molecular imaging of prostate cancer
por: Shapovalova, Mariya, et al.
Publicado: (2018)

A-Methylacyl-CoA Racemase (AMACR) and Prostate-Cancer Risk: A Meta-Analysis of 4,385 Participants
por: Jiang, Ning, et al.
Publicado: (2013)

Correction: Exploiting the transcriptional specificity of the alpha-methylacyl-CoA racemase AMACR promoter for the molecular imaging of prostate cancer
por: Shapovalova, Mariya, et al.
Publicado: (2019)

Correction: A-Methylacyl-CoA Racemase (AMACR) and Prostate-Cancer Risk: A Meta-Analysis of 4,385 Participants
por: Jiang, Ning, et al.
Publicado: (2013)

Detection of Alpha-Methylacyl-CoA Racemase (AMACR), a Biomarker of Prostate Cancer, in Patient Blood Samples Using a Nanoparticle Electrochemical Biosensor
por: Lin, Po-Yuan, et al.
Publicado: (2012)

Asymptomatic retinal dysfunction in alpha-methylacyl-CoA racemase deficiency
por: Alsalamah, Abrar K., et al.
Publicado: (2021)

Increased expression of α-methylacyl-coenzyme A racemase (AMACR; p504s) and p16 in distal hyperplastic polyps
por: Dayi, Nimet, et al.
Publicado: (2013)

Diagnostic utility of a-methylacyl COA racemase in prostate cancer of the Iranian population
por: Taheri, Diana, et al.
Publicado: (2021)

Expression and Characterization of α-Methylacyl CoA Racemase from Anisakis simplex Larvae
por: Kim, Bong Jin, et al.
Publicado: (2012)

Diagnostic Accuracy of Alpha-Methylacyl-CoA Racemase Immunohistochemical Expression for the Diagnosis of Ovarian and Endometrial Clear Cell Carcinomas
por: Nili, Fatemeh, et al.
Publicado: (2023)

MRI characterisation of adult onset alpha-methylacyl-coA racemase deficiency diagnosed by exome sequencing
por: Haugarvoll, Kristoffer, et al.
Publicado: (2013)

The auxiliary diagnostic value of prostate-specific antigen and α-methylacyl-CoA racemase in prostate cancer
por: Yang, Daijun, et al.
Publicado: (2020)

Autoantibody Positivity in Two Bahraini Siblings With a Novel Alpha-Methylacyl-CoA Racemase Mutation
por: Isa, Hasan M, et al.
Publicado: (2023)

Diagnostic utility of α-methylacyl CoA racemase (P504S) & HMWCK in morphologically difficult prostate cancer
por: Kumaresan, K, et al.
Publicado: (2010)

Pseudohyperplastic variant of adenocarcinoma as a component of α-methyl–CoA-racemase (AMACR negative) carcinosarcoma of the prostate
por: Dudani, Sharmila, et al.
Publicado: (2015)

Genetic Variations of α-Methylacyl-CoA Racemase Are Associated with Sporadic Prostate Cancer Risk in Ethnically Homogenous Koreans
por: Lee, Sang-Jin, et al.
Publicado: (2013)

Significance of overexpression of alpha methylacyl-coenzyme A racemase in hepatocellular carcinoma
por: Li, Wei, et al.
Publicado: (2008)

Alpha-methylacyl-coenzyme A racemase expression in neuroendocrine neoplasms of the stomach
por: Annenkov, Alexey, et al.
Publicado: (2012)

Gastric neuroendocrine carcinoma with positive staining for prostate cancer markers including prostate-specific antigen and alpha-methylacyl-CoA racemase
por: Hakozaki, Yuji, et al.
Publicado: (2018)

Alpha-Methylacyl-Coenzyme A Racemase-Expressing Urachal Adenocarcinoma of the Abdominal Wall
por: Ha, Yun-Sok, et al.
Publicado: (2010)

Prostate Cancer Diagnosis Using Urine Sediment Analysis-Based α-Methylacyl-CoA Racemase Score: A Single-Center Experience
por: Ji, Jin, et al.
Publicado: (2019)

Use of immunohistochemical analysis of CK5/6, CK14, and CK34betaE12 in the differential diagnosis of solid papillary carcinoma in situ from intraductal papilloma with usual ductal hyperplasia of the breast
por: Maeda, Ichiro, et al.
Publicado: (2018)

Aberrant expression and potency as a cancer immunotherapy target of alpha-methylacyl-coenzyme A racemase in prostate cancer
por: Honma, Ichiya, et al.
Publicado: (2009)

Diagnostic Roles of Immunohistochemical Markers CK20, CD44, AMACR, and p53 in Urothelial Carcinoma In Situ
por: Yoo, Daeseon, et al.
Publicado: (2023)

Suppression of α-methylacyl-coenzyme A racemase by miR200c inhibits prostate adenocarcinoma cell proliferation and migration
por: Xie, Hanbing, et al.
Publicado: (2020)

Immunohistochemical Expression of Alpha-Methyl-Coa (AMACR) and ERG in Prostatic Adenocarcinoma and Prostatic Hyperplasia: A Comparative Study
por: Samir Sayed, Rasha Mohamed, et al.
Publicado: (2023)

Does the addition of AMACR to CK20 help to diagnose challenging cases of urothelial carcinoma in situ?
por: Alston, Erin L. J., et al.
Publicado: (2019)

Combined α-methylacyl-CoA racemase inhibition and docetaxel treatment reduce cell proliferation and decrease expression of heat shock protein 27 in androgen receptor-variant-7–positive prostate cancer cells
por: Yoshizawa, Atsuhiko, et al.
Publicado: (2021)

Expression of 34βE12 may be an independent predictor of survival in breast cancer
por: Wang, Chuchu, et al.
Publicado: (2021)

Immunohistochemical profiling of Ameloblastomas using cytokeratin, vimentin, smooth muscle actin, CD34 and S100
por: Sherlin, Herald J., et al.
Publicado: (2013)

CK20 versus AMACR and p53 immunostains in evaluation of Urothelial Carcinoma in Situ and Reactive Atypia
por: Neal, Daniel J., et al.
Publicado: (2020)

Oncogenic Activity of Solute Carrier Family 45 Member 2 and Alpha‐Methylacyl‐Coenzyme A Racemase Gene Fusion Is Mediated by Mitogen‐Activated Protein Kinase
por: Zuo, Ze‐Hua, et al.
Publicado: (2021)

Invasive Lobular Carcinomas Do Not Express Basal Cytokeratin Markers CK5/6, CK14 and CK17
por: Khilko, Natalya, et al.
Publicado: (2010)

3,4-Dimethyl-N-[(E)-3-nitrobenzylidene]-1,2-oxazol-5-amine
por: Asiri, Abdullah M., et al.
Publicado: (2010)

p40 as a Basal Cell Marker in the Diagnosis of Prostate Glandular Proliferations: A Comparative Immunohistochemical Study with 34betaE12
por: Brustmann, Hermann
Publicado: (2015)

N-[(E)-Anthracen-9-ylmethylidene]-3,4-dimethyl-1,2-oxazol-5-amine
por: Asiri, Abdullah M., et al.
Publicado: (2011)

Current Knowledge on the Function of α-Methyl Acyl-CoA Racemase in Human Diseases
por: Kong, Gyeyeong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h95k1lci7t1pca2ka26nfo3g48